Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
Condition: Primary Immune Deficiency Disorder Intervention: Biological: Immunoglobulin Sponsor: Green Cross Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2018 Category: Research Source Type: clinical trials